– Hughes & Company, a private equity firm focused on healthcare software and technology-enabled services, closed its second fund, Hughes Growth Equity Fund II, L.P., at its hard cap of $260 million, exceeding the $200 million target.
– Travis Hughes, Managing Partner and Founder, expressed gratitude to investors and emphasized the firm’s 15-year commitment to building companies that improve efficiency and reduce costs in healthcare.
– The Hughes & Company investment team consists of healthcare experts, operators, and thought leaders with a track record of creating substantial value.
– Naile Berna Kovuk, Managing Partner, highlighted the importance of investing in the firm’s team and culture to strengthen partnerships with management teams and create lasting value.
– Founded in 2010, Hughes & Company has a successful track record in healthcare software and technology-enabled services.
– Hughes Growth Equity Fund I, L.P. closed in 2021 at $116 million and backed several growth-stage companies, including Azara Healthcare, which was sold to Insight Partners in late 2024.
– Fund II’s first investment was the merger of Curvo and BroadJump, creating a unified spend management and analytics platform for hospitals and health systems, aimed at reducing costs, improving sourcing efficiency, and enhancing outcomes.
